factMR-logo.png
Preimplantation Genetic Testing Market Value To Top Us$ 1.4 Billion By 2032 : Fact.MR Study
March 09, 2023 10:00 ET | FACT.MR
Rockville, March 09, 2023 (GLOBE NEWSWIRE) -- The global preimplantation genetic testing market is projected to grow at a staggering 9% value CAGR, reaching US$ 1,420 Million, following an...
logo.jpg
RENNOVA HEALTH ENTERS INTO AN AGREEMENT TO SEPARATE ITS SOFTWARE AND GENETIC DIAGNOSTICS INTERPRETATION DIVISIONS
June 12, 2020 09:23 ET | Rennova Health, Inc.
WEST PALM BEACH, Fla., June 12, 2020 (GLOBE NEWSWIRE) -- Rennova Health, Inc. (OTC: RNVA), (OTC: RNVAW) (“Rennova” or the “Company”), a vertically integrated provider of industry-leading diagnostics...
logo.jpg
RENNOVA HEALTH REPORTS SECOND QUARTER 2018 FINANCIAL RESULTS
August 14, 2018 09:20 ET | Rennova Health, Inc.
WEST PALM BEACH, Fla, Aug. 14, 2018 (GLOBE NEWSWIRE) -- Rennova Health, Inc. (OTC: RNVA), (OTC: RNVAW), (“Rennova” or the “Company”) a vertically integrated provider of industry-leading...
Taconic_Logo_Vert_Process_Medium resize.jpg
Taconic Biosciences Announces Partnership With Cergentis B.V. to Provide Transgene Mapping Services
August 08, 2017 16:43 ET | Taconic Biosciences
HUDSON, N.Y., Aug. 08, 2017 (GLOBE NEWSWIRE) -- Taconic Biosciences, a global leader in genetically engineered mouse models and associated services, announced it has signed a collaborative agreement...